It has been suggested that hyperinsulinemia activates SREBP1c to promote hepatic TG accumulation in NAFLD patients, though the detailed mechanism remains unclear. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.